HUP0103650A3 - Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue - Google Patents

Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue

Info

Publication number
HUP0103650A3
HUP0103650A3 HU0103650A HUP0103650A HUP0103650A3 HU P0103650 A3 HUP0103650 A3 HU P0103650A3 HU 0103650 A HU0103650 A HU 0103650A HU P0103650 A HUP0103650 A HU P0103650A HU P0103650 A3 HUP0103650 A3 HU P0103650A3
Authority
HU
Hungary
Prior art keywords
epitopes
detection
directed against
specific antibodies
antibodies directed
Prior art date
Application number
HU0103650A
Other languages
English (en)
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of HUP0103650A2 publication Critical patent/HUP0103650A2/hu
Publication of HUP0103650A3 publication Critical patent/HUP0103650A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HU0103650A 1998-03-27 1999-03-29 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue HUP0103650A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98870060A EP0947525A1 (en) 1998-03-27 1998-03-27 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue
PCT/EP1999/002154 WO1999050301A2 (en) 1998-03-27 1999-03-29 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue

Publications (2)

Publication Number Publication Date
HUP0103650A2 HUP0103650A2 (hu) 2002-01-28
HUP0103650A3 true HUP0103650A3 (en) 2005-10-28

Family

ID=8237012

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103650A HUP0103650A3 (en) 1998-03-27 1999-03-29 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue

Country Status (19)

Country Link
US (2) US6521403B1 (hu)
EP (2) EP0947525A1 (hu)
JP (1) JP3657515B2 (hu)
KR (1) KR20010042225A (hu)
CN (1) CN1294598A (hu)
AT (1) ATE336512T1 (hu)
AU (1) AU756495B2 (hu)
BR (1) BR9909026A (hu)
CA (1) CA2321179A1 (hu)
DE (1) DE69932812T2 (hu)
ES (1) ES2272065T3 (hu)
HU (1) HUP0103650A3 (hu)
IL (1) IL138586A0 (hu)
NZ (1) NZ506553A (hu)
PL (1) PL343638A1 (hu)
PT (1) PT1064309E (hu)
TR (1) TR200002695T2 (hu)
WO (1) WO1999050301A2 (hu)
ZA (1) ZA200004383B (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150134A (en) * 1994-07-29 2000-11-21 Innogenetics, N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
US20030180284A1 (en) * 1998-11-05 2003-09-25 Board Of Trustees Of Leland Stanford Junior University Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes
HUP0203195A3 (en) * 1999-10-27 2004-07-28 Innogenetics Nv Redox reversible hcv proteins with native-like conformation
EP1535628B1 (en) * 1999-11-24 2013-07-31 Novartis Vaccines and Diagnostics, Inc. Hbv/hcv virus-like particle
EP1178116A1 (en) * 2000-08-03 2002-02-06 Hybrigenics S.A. Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof
WO2002055560A2 (en) * 2000-12-01 2002-07-18 The Gouvernment Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c
DE60231475D1 (de) * 2001-01-12 2009-04-23 Molecules Of Man Ab Materialien und methoden zur behandlung von hepatitis c
KR20060087574A (ko) * 2003-09-22 2006-08-02 가부시키가이샤 그린 펩티드 Ｃ형 간염 바이러스 유래 펩티드
EP1574517A1 (en) * 2004-03-09 2005-09-14 Innogenetics N.V. HCV E1 comprising specific disulfide bridges
EP1602664A1 (en) * 2004-03-08 2005-12-07 Innogenetics N.V. HCV E1 comprising specific disulfide bridges
US7309589B2 (en) * 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
WO2006033012A2 (en) * 2004-09-24 2006-03-30 Pfizer Limited Method of screening for modulators of hepatitis c virus infection
WO2008150282A1 (en) * 2006-02-23 2008-12-11 University Of California, San Diego Ribosomal s-6 kinase (rsk) inhibitory peptides and method of use thereof
US20090311248A1 (en) * 2006-03-22 2009-12-17 Erik Depla Hepatitis C Virus Neutralizing Antibodies
JP5031827B2 (ja) * 2006-06-01 2012-09-26 程云 予防或いは肝損傷を治療するペプチッド
MX2009008706A (es) 2007-02-21 2009-09-14 Univ Massachusetts Anticuerpos humanos contra el virus de la hepatitis c (hcv) y usos de los mismos.
JP5608087B2 (ja) 2008-09-30 2014-10-15 東レ株式会社 Ｃ型肝炎ウイルスのエンベロープタンパク質２に結合する抗体及びそれを用いたｃ型肝炎ウイルスの遺伝子型の同定方法
US20100104555A1 (en) * 2008-10-24 2010-04-29 The Scripps Research Institute HCV neutralizing epitopes
WO2014065822A1 (en) * 2012-10-26 2014-05-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Hepatitis c virus neutralizing epitopes, antibodies, and methods
EP3274707B1 (en) * 2015-03-23 2022-11-30 Sartorius BioAnalytical Instruments, Inc. Evaluating biological material for unassociated virus-size particles of adenovirus or adeno-associated virus viral type
CN109160942B (zh) * 2018-09-26 2021-06-29 广州市第八人民医院 Hcv包膜蛋白高度保守区域的肽段502-518及其用途
CN109232722B (zh) * 2018-09-26 2021-06-29 广州市第八人民医院 Hcv包膜蛋白高度保守区域的肽段317-325及其用途
KR20230050761A (ko) 2021-10-08 2023-04-17 김민준 과제기한 자동알림

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308750A (en) 1989-12-22 1994-05-03 Abbott Laboratories Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same
DK0556292T4 (da) 1990-11-08 2006-12-27 Novartis Vaccines & Diagnostic Hepatitis C virus asialoglycoproteiner
JP3483555B2 (ja) * 1991-01-31 2004-01-06 アボット・ラボラトリーズ 推定ｈｃｖエンベロープ領域に対するモノクローナル抗体およびその使用方法
FR2677372B1 (fr) 1991-06-06 1994-11-10 Pasteur Institut Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques.
DE4209215A1 (de) * 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
IT1249684B (it) 1991-07-19 1995-03-09 Sorin Biomedica Spa Epitopi della proteina env del virus dell'epatite c.
ES2210235T3 (es) 1992-01-31 2004-07-01 Abbott Laboratories Sistemas de expresion de mamiferos para proteinas de hcv.
BR9305435A (pt) * 1992-03-06 1994-12-27 Innogenetics Nv Processo para determinação de peptídeos correspondendo a epítopos imunologicamente importantes e seu uso em um processo para determinação de anticorpos ou peptídeos biotinilados correspondendo a epítopos imunologicamente importantes, processo para preparação dos mesmos e composições contendo os mesmos
JPH05344899A (ja) 1992-06-11 1993-12-27 Kokuritsu Yobou Eisei Kenkyusho Ｃ型肝炎ウイルス外被タンパク質の産生法
BR9306984A (pt) * 1992-08-27 1999-01-12 Deakin Res Ltd Análogo de antígeno de peptídeo de um antígeno de peptídeo nativo vacina anticorpo processo para vacinar um hospedeiro necessitando deste tratamento estojo diagnóstico processos para preparar um análogo de um antiígeno de um antígeno de peptídeo nativo para preparar uma vacina para analisar uma amostra para um antígeno de peptídeo nativo e para analisar uma amostra para um anticorpo
US5514539A (en) 1993-06-29 1996-05-07 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of the envelope 1 gene of 51 isolates of hepatitis C virus and the use of reagents derived from these sequences in diagnostic methods and vaccines
US5610009A (en) 1994-01-28 1997-03-11 Abbott Laboratories Mammalian expression systems for hepatitis C virus envelope genes
US6150134A (en) 1994-07-29 2000-11-21 Innogenetics, N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
US6110465A (en) * 1995-06-07 2000-08-29 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and deduced amino acid sequences of hypervariable region 1 of the envelope 2 gene of isolates of hepatitis C virus and the use of reagents derived from these hypervariable sequences in diagnostic methods and vaccines

Also Published As

Publication number Publication date
ATE336512T1 (de) 2006-09-15
DE69932812D1 (de) 2006-09-28
ZA200004383B (en) 2003-01-28
ES2272065T3 (es) 2007-04-16
JP3657515B2 (ja) 2005-06-08
IL138586A0 (en) 2001-10-31
US6841353B2 (en) 2005-01-11
US20030129746A1 (en) 2003-07-10
PT1064309E (pt) 2006-12-29
CA2321179A1 (en) 1999-10-07
AU756495B2 (en) 2003-01-16
EP0947525A1 (en) 1999-10-06
CN1294598A (zh) 2001-05-09
WO1999050301A3 (en) 1999-11-25
JP2002510038A (ja) 2002-04-02
KR20010042225A (ko) 2001-05-25
US6521403B1 (en) 2003-02-18
EP1064309B1 (en) 2006-08-16
EP1064309A2 (en) 2001-01-03
WO1999050301A2 (en) 1999-10-07
BR9909026A (pt) 2000-12-05
NZ506553A (en) 2002-11-26
AU3602299A (en) 1999-10-18
HUP0103650A2 (hu) 2002-01-28
TR200002695T2 (tr) 2000-12-21
PL343638A1 (en) 2001-08-27
DE69932812T2 (de) 2007-04-12

Similar Documents

Publication Publication Date Title
HUP0103650A3 (en) Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
HUP0102478A3 (en) Particles of hcv envelope proteins: use for vaccination
HUP0004327A1 (en) Fusion proteins containing human papilloma virus (hpv) proteins and immunological fusion partner with t-helper epitopes to the hpv antigen, as well as vaccine formulations for treatment and/or profilaxis of hpv induced lesions
HUP0002176A3 (en) Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
AU2903999A (en) Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
PL346213A1 (en) Immunological herpes simplex virus antigens and methods for use thereof
HK1069600A1 (en) Method for detection or determination of hcv core antigens and reagent for detection or determination for use therein
IL112316A0 (en) T cell antigen receptor v region proteins and methods of preparation thereof
GB9502489D0 (en) Expression of the non-structural protein NS1 of influenza virus and detection of anti-NS1 antibody in serum
AU2002220460A1 (en) The polypeptide fragments of hepatitis e virus, the vaccine composition comprising said fragments and the diagnostic kits
EP0717104A3 (en) Immunoassays of non-A, non-B hepatitis virus related antigens, monoclonal antibodies and these hybridomas synthesizing them
NZ314496A (en) Anti fas recombinant antibody protein, dna, vectors, host cells and preparation thereof
DE60042130D1 (de) Neue antigene hev-peptide und methoden
AU1763097A (en) Detection of prostate-specific antigen in breast tumors and serum
EP1136555A4 (en) TUMORANT PROTEIN ART-1 AND TUMORANT PEPTIDES THEREOF
IL138804A0 (en) Hepatitis c virus ns5b nucleic acids and proteins
AU2540897A (en) Methods and compositions of chimeric polypeptides for tumor antigen vaccines
IL145440A0 (en) Synthetic hcv envelope proteins and their use for vaccination
WO1999024466A3 (en) Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes
EP1268749A4 (en) REAGENTS AND DIAGNOSTIC METHODS FOR ANTIBODY AGAINST THE SURFACE ANTIGEN OF HEPATITIS B AND ANTIBODY AGAINST HEPATITIS B VIRUS
PL363175A1 (en) Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
AU1705397A (en) Proteins and peptides for contraceptive vaccines and fertility diagnosis
IL106592A0 (en) Peptides,analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
ZA200007318B (en) Particles of HCV envelope proteins: use for vaccination.
SI1090033T1 (en) Particles of hcv envelope proteins: use for vaccination